In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
9 weeks 4 days ago
13 weeks 5 days ago
15 weeks 2 days ago
15 weeks 3 days ago
27 weeks 5 days ago
33 weeks 3 days ago
44 weeks 3 days ago
45 weeks 3 days ago
47 weeks 3 hours ago
47 weeks 3 days ago